Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 779

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 779
---
 to the Merger owned, in aggregate and on a fully-diluted basis, approximately 97.15% of the Company (or 94.55% of the Company after giving effect to the issuance of the CVR Shares assuming the
Milestone has been achieved) and Company securityholders as of immediately prior to the Merger owned, in aggregate and on a fully-diluted basis, approximately 2.85% of the Company (or 5.45% of the Company after giving effect to the issuance of the
CVR Shares assuming the Milestone has been achieved).

On October 18, 2024, effective immediately prior to the consummation of the
Merger, the Company completed a 1-for-35 reverse stock split (the “2024 Reverse Stock Split”) of its issued and outstanding common stock in connection with the
Merger Agreement with TuHURA. As a result of the 2024 Reverse Stock Split, every 35 shares of issued and outstanding common stock were converted into one share of common stock. Any fractional shares of common stock resulting from the 2024 Reverse
Stock Split were rounded up to the nearest whole post-2024 Reverse Stock Split share. The 2024 Reverse Stock Split did not change the par value of the Company’s common stock or the amount of authorized common stock. All outstanding securities
entitling their holders to acquire shares of common stock were adjusted as a result of the 2024 Reverse Stock Split. All common share and per share data are retrospectively restated to give effect to the 2024 Reverse Stock Split for all periods
presented herein.

F-46

Kintara Therapeutics, Inc. Condensed Consolidated Interim Balance Sheets (In thousands, except par value amounts)

|                                                                                   |     | Note |   |     | December 31, 
 2023         
 $            |          |   |     | June 30, 
 2023     
 $        |          |   |
|:----------------------------------------------------------------------------------|:----|:-----|--:|:----|:-------------|---------:|:--|:----|:---------|---------:|:--|
|                                                                                   |     |      |   |     | -unaudited   |          |   |     |          |          |   |
| Assets                                                                            |     |      |   |     |              |          |   |     |          |          |   |
| Current assets                                                                    |     |      |